What is a stock summary page? Click here for an overview.
Business Description
Redcare Pharmacy NV
ISIN : NL0012044747
Compare
Compare
Traded in other countries / regions
RDC.Germany0RJT.UKSAEYY.USASHOP.Austria IPO Date
2016-10-27Description
Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue domestically from the DACH segment. Geographically, it has a presence in Germany, Austria, Switzerland, Netherlands, Belgium, Spain, France, and Italy.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.86 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.48 | |||||
| Debt-to-EBITDA | 5.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.69 | |||||
| Beneish M-Score | -2.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.6 | |||||
| 3-Year EBITDA Growth Rate | 51.8 | |||||
| 3-Year EPS without NRI Growth Rate | -3.7 | |||||
| 3-Year Book Growth Rate | 3.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 25.91 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38 | |||||
| 9-Day RSI | 47.43 | |||||
| 14-Day RSI | 50.02 | |||||
| 3-1 Month Momentum % | -13.04 | |||||
| 6-1 Month Momentum % | -3.15 | |||||
| 12-1 Month Momentum % | -18.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | |||||
| Quick Ratio | 1.53 | |||||
| Cash Ratio | 0.86 | |||||
| Days Inventory | 28.81 | |||||
| Days Sales Outstanding | 17.73 | |||||
| Days Payable | 35.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.5 | |||||
| Shareholder Yield % | 0.24 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.2 | |||||
| Operating Margin % | -0.96 | |||||
| Net Margin % | -1.1 | |||||
| FCF Margin % | -0.47 | |||||
| ROE % | -4.76 | |||||
| ROA % | -2.37 | |||||
| ROIC % | -3.01 | |||||
| 3-Year ROIIC % | -4.66 | |||||
| ROC (Joel Greenblatt) % | -13.86 | |||||
| ROCE % | -2.57 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 912.8 | |||||
| PS Ratio | 1.13 | |||||
| PB Ratio | 4.97 | |||||
| Price-to-Tangible-Book | 27.7 | |||||
| Price-to-Operating-Cash-Flow | 81.01 | |||||
| EV-to-EBIT | -125.57 | |||||
| EV-to-Forward-EBIT | 111.3 | |||||
| EV-to-EBITDA | 53.34 | |||||
| EV-to-Forward-EBITDA | 37.16 | |||||
| EV-to-Revenue | 1.17 | |||||
| EV-to-Forward-Revenue | 1 | |||||
| EV-to-FCF | -254.7 | |||||
| Price-to-GF-Value | 0.74 | |||||
| Price-to-Projected-FCF | 116.94 | |||||
| Price-to-Net-Current-Asset-Value | 1052.5 | |||||
| Earnings Yield (Greenblatt) % | -0.8 | |||||
| FCF Yield % | -0.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redcare Pharmacy NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,226.756 | ||
| EPS (TTM) (€) | -1.232 | ||
| Beta | 1.39 | ||
| 3-Year Sharpe Ratio | 0.39 | ||
| 3-Year Sortino Ratio | 0.61 | ||
| Volatility % | 29.4 | ||
| 14-Day RSI | 50.02 | ||
| 14-Day ATR (€) | 7.220434 | ||
| 20-Day SMA (€) | 125.7225 | ||
| 12-1 Month Momentum % | -18.72 | ||
| 52-Week Range (€) | 95.75 - 171.2 | ||
| Shares Outstanding (Mil) | 20.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Redcare Pharmacy NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redcare Pharmacy NV Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Redcare Pharmacy NV Frequently Asked Questions
What is Redcare Pharmacy NV(LTS:0RJT)'s stock price today?
The current price of LTS:0RJT is €126.30. The 52 week high of LTS:0RJT is €171.20 and 52 week low is €95.75.
When is next earnings date of Redcare Pharmacy NV(LTS:0RJT)?
The next earnings date of Redcare Pharmacy NV(LTS:0RJT) is .
Does Redcare Pharmacy NV(LTS:0RJT) pay dividends? If so, how much?
Redcare Pharmacy NV(LTS:0RJT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers